Theseus Pharmaceuticals, Inc. (THRX) Financials
Stock symbol THRX is outdated, potentially delisted? Maybe it is available on other exchange?
THRX Assets vs Liabilities
| Date | Assets | Liabilities |
|---|---|---|
| 2023-09-30 | 234.6 million | 10.1 million |
| 2023-06-30 | 245.1 million | 11.0 million |
| 2023-03-31 | 255.6 million | 10.1 million |
| 2022-12-31 | 222.4 million | 14.8 million |
THRX Free Cash Flow and Stock based compensation
Graph available only for supporters. Become a supporter to see it.
| Date | Free Cash Flow | Stock based compensation |
|---|---|---|
| 2023-09-30 | -11.1 million | 3.6 million |
| 2023-06-30 | -10.1 million | 3.6 million |
| 2023-03-31 | -18.6 million | 3.0 million |
| 2022-12-31 | -9.9 million | 2.4 million |
THRX Net Income
No data available :(
THRX Cash and Debt
Graph available only for supporters. Become a supporter to see it.
| Date | Cash | Debt | Capital Lease |
|---|---|---|---|
| 2023-09-30 | 205.1 million | - | 3.7 million |
| 2023-06-30 | 208.2 million | - | 3.8 million |
| 2023-03-31 | 236.6 million | - | 3.9 million |
| 2022-12-31 | 198.0 million | - | 4.0 million |
THRX Shares Outstanding
THRX Expenses
Graph available only for supporters. Become a supporter to see it.
| Date | Capex | R&D | G&A | S&M |
|---|---|---|---|---|
| 2023-09-30 | 50000 | 11.5 million | 4.9 million | - |
| 2023-06-30 | 11000 | 12.9 million | 4.7 million | - |
| 2023-03-31 | 11000 | 12.4 million | 4.7 million | - |
| 2022-12-31 | 11000 | 10.4 million | 5.1 million | - |
THRX Cost of Revenue
Graph available only for supporters. Become a supporter to see it.
| Date | Revenue | Cost of Revenue |
|---|---|---|
| 2023-09-30 | - | 22507 |
| 2023-06-30 | - | 158709 |
| 2023-03-31 | - | 155153 |
| 2022-12-31 | - | 152000 |
THRX
Price: $4.06
52 week price:
Payout Ratio Range:
Earnings Per Share: -1.34 USD
P/E Ratio: -3.03
Exchange: NMS
Sector: Healthcare
Industry: Biotechnology
Volume: 134600
Market Capitalization: 181.3 million
Average Dividend Frequency: 3